European Pharmacovigilance Congress 2024
Panoramica della conferenza
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences.
EUPV congress is proud to have high quality scientific content as its main characteristic which has attracted growing interest from speakers, sponsors and participants from all over the world.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors,) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
To further improve the value of the congress and continuously make it more and more interesting by bringing new ideas and scientific contents, this year the Scientific Board has been further widened with the addition of new PV key opinion leaders who need no introduction since their knowledge and skills are world class.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress will be a mixed event!
18-19 November | Virtual 9 am- 6 pm
21 November | APERITIF TIME, NH Milano Congress Centre 6 pm – 9 pm
22 November | Face to face, NH Milano Congress Center 9.30 am – 5 pm
APERITIF TIME – November 21 from 6 to 9 pm – NH Milano Congress
Reserve your place to meet and network with your colleagues and experts!
This year the congress will include:
– 25 Topics
– 11 virtual & face to face parallel sessions
– 25 interactives round tables
– 2 face to face workshops
– 2 LECTIO Magistralis
Perchè partecipare?
- Learn about the latest PV trends and updates
- Share experiences and solutions at A leading european event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
TOPICS 2024 IN PROGRESS
THEMATIC SESSIONS
18/11 – Virtual
– BIOLOGICAL BASIS OF ADVERSE REACTIONS WITH FOCUS ON SCARS
– IMMUNOLOGICAL ADVERSE REACTIONS
– SIGNAL DETECTION
– RISK MANAGEMENT
– COMMUNICATING SAFETY INFORMATION IN THE DIGITAL ERA
19/11 – Virtual
– AUTHORITIES’ ASSESSMENT OF PV INFORMATION
– REAL WORD DATA & REAL WORD EVIDENCE
– MANUFACTURING & PV INTERFACES
– DRUG SAFETY IN MARKETING AUTHORIZATION APPLICATIONS
– EVOLVING LANDSCAPE OF ELECTRONIC SAFETY DATA IN PV
– NON-EU PV REQUIREMENTS
22/11 – Milan
– EVOLVING PHARMACOVIGILANCE STRATEGIES
– MAIN GLOBAL AND LOCAL PV UPDATES
– PRACTICAL EXPERIENCE OF APPLYING ARTIFICIAL INTELLIGENCE IN PV
– AUDIT &INSPECTIONS
and more parallel sessions coming …
27 November 2023 – VIRTUAL / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Gian Nicola Castiglione, Director Global Pharmacovigilance, EU QPPV | Chiesi
Thierry Hamard, Pharmacovigilance & Regulatory Intelligence | Safety Observer
Marcela Fialova, COO and Co-founder | iVigee
Ilaria Grisoni, Executive Director, Head of EU/International PV & Global Risk Management and EEA QPPV | Jazz Pharmaceuticals
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Klaudija Marijanovic Barac, Sr. Director, EU&UK QPPV deputy, Head Periodic Reports & Risk Management Unit at TEVA
Qun-Ying Yue, Associate Professor, Senior Pharmacovigilance Expert | Uppsala Monitoring Centre
Zeljana Margan Koletic, Senior Manager, Risk Management Plans (RMP) Team Leader | Teva
Annette Rudolph, Pharmacovigilance scientist | Uppsala Monitoring Centre
Michael Von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars | Biogen International
Thomas Debray, Founder, Smart Data Analysis and Statistics B.V.
Susana Perez-Gutthann, Vice President, Global Head Epidemiology | RTI International
Gianluca Trifirò, Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Jan Petracek, CEO | iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Kendal Harrison, Head of Vigilance Development MHRA
Maria Beatrice Panico, Principal consultant at Scendea
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Ivona Bahnik Bisevac, Director Benefit-Risk Management | PrimeVigilance
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Slot reserved for the sponsor
Maddalena Lino, Safety risk Lead Director Pfizer
Nicholas Moore, Emeritus professor of clinical pharmacology | University of Bordeaux
28 November 2023 – VIRTUAL / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Margherita D’Antuono, EU-UK QPPV | Piramal Critical Care
Fazil Afzal, Senior Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Eriko Ogura, Global Head of Drug Safety | Shionogi & Co.,Ltd.
Niteeka Maroo, Head Pharmacovigilance | Piramal Group-India
Hervé Le Louët, Head of PV policy intelligence strategy | Takeda, CIOMS President
Frederic Bouder, Professor in Risk Management, University of Stavanger, Norway
Anita Blackburn, Global Labeling Lead | Labcorp
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Nuccia Oneto, Patient Oriented Programmes Governance Lead | Novartis Italy
Chairperson PEC
Calin Lungu, DDCS S.A., CEO
Mattia Calissano, Head of Pharmacovigilance | Orchard Therapeutics
Jan Petracek, CEO | iVigee
Larissa Mege, Global Safety Officer, Sanofi Rare Diseases, Specialty Care Business Unit
Anne De Groot, CEO/CSO and Director | EpiVax
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Sara Lazzarin, Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Vojtech Kvita, CVO, Co-Founder | NextPV Services
Glyn Belcher, CEO of PV Consultancy Ltd
Amalia Alexe, Policy & Liaison Lead, QPPV PRRC Office | Novartis
Jennifer Stevenson, Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation TrusT
Valentina Mancini, Senior Director Pharmacovigilance QPPV | Shionogi Europe
Romina Fernanda Heredia, PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Lana Arafat, Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Gloria Bustos, Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
1 December 2023 – FACE-TO-FACE IN MILAN / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Lembit Rago, Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Eriko Ogura, Global Head of Drug Safety- Shionogy
Ayman Ayoub, VP Business Unit Area Head Safety Surveillance & Risk Management | Pfizer
Andrew Bate, VP Safety Innovation & Analytics | GSK
Sophia Trantza, Senior pharmacovigilance expert
Anna Ruth van Troostenburg De Bruyn, Senior VP Pharmacovigilance & Epidemiology | Gilead Sciences
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Maria Beatrice Panico, Principal consultant at Scendea
Anne Ruth van Troostenburg De Bruyn, EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Elena Prokofjeva, Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Monica Da Luz Carvalho Soares, Health Regulatory Expert, Pharmacovigilance Adviser|Brazilian Health Surveillance Agency (Anvisa)
Calin Lungu, DDCS S.A., CEO
AIFA representative (invited)
PV inspector | FAGG -AFMPS (tbc)
Tea Babić, Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Hrvoje Maček, VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Laura Boga, Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Lucia Biagiotti, EU & UK QPPV, Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Andrea Pieri, Business Development Director | Pharma D&S
Scientific board 2024
Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK
Glyn Belcher
CEO | PV Consultancy Ltd
Mattia Calissano
Head of Pharmacovigilance | Orchard Therapeutics
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Past Head of Global Pharmacovigilance and EU-UK QPPV at Chiesi Farmaceutici S.p.A.
Mircea Ciuca
MD, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Calin Lungu
DDCS S.A., CEO
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV, Shionogi Europe
Jan Petracek
CEO, iVigee, Director, Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech, Chairperson for EUPV Congress
Speakers 2024 – In Progress…
Mayssa AbouGhannam
Country Safety Team Lead, Saudi Arabia, Gulf, Pakistan, Afghanistan | Johnson & Johnson
Fazil Afzal
Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Klaudija Marijanovic Barac
Sr. Director, EU&UK QPPV deputy, Head Periodic Reports and Risk Management Centre | TEVA
Andrew Bate
VP Safety Innovation & Analytics | GSK
Glyn Belcher
CEO | PV Consultancy Ltd
John -Joseph Borg
Director Post-Licensing | Malta Medicines Authority
Margherita D’Antuono
EU-UK QPPV| Piramal Critical Care
Anne De Groot
CEO/CSO and Director | Epivax
Roxana Dondera
Head of Pharmacovigilance and Risk Management Unit | National Agency for Medicine and Medical Devices of Romania
Iva Galic
Pharmacovigilance Inspector Expert | HALMED
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Terenzio Ignoni
SVP Quality and CMC | Gain Therapeutics
Vibha Jawa
Executive director | Bristol Myers Squibb
Calin Lungu
DDCS S.A., CEO
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Zeljana Margan Koletic
Senior Manager, Risk Management Plans (RMP) Team Leader | Teva
Robert Massouh
Head of (PV) Risk Management and Benefit Risk Evaluation | Gsk
Nicholas Moore
Emeritus Professor, specialist in Cardiology and Pharmacology | University of Bordeaux
Iva Novak
Head of European Pharmacovigilance and EU QPPV | Teva
Maria Beatrice Panico
Principal Consultant | Scendea
Georgios Papazisis
Professor of Clinical Pharmacology; Medical Director, Clinical Research Unit | School of Medicine, Aristotle University of Thessaloniki
Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Amy Rosemberg
Senior Director and Consultant, Immunology | EpiVax, Inc
Geeta Shanbhag
VP Pharmacovigilance and Medico- Regulatory Affairs | Ipca Laboratories Ltd
Sofia Trantza
Senior Pharmacovigilance Expert , PRAC member Greece
Chia Yu Chu
Prof. Department of Dermatology | National Taiwan University
Sponsors & Media Partners EUPV2023 – SPONSORS 2024 IN PROGRESS
Diventa sponsor
The European Pharmacovigilance Congress provides an excellent opportunity to get in touch with PV professionals and decision makers through a powerful virtual exhibition area. To sponsor the event, contact us.
Sede del congresso
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on November 22! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
Panoramica della conferenza
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences.
EUPV congress is proud to have high quality scientific content as its main characteristic which has attracted growing interest from speakers, sponsors and participants from all over the world.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors,) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
To further improve the value of the congress and continuously make it more and more interesting by bringing new ideas and scientific contents, this year the Scientific Board has been further widened with the addition of new PV key opinion leaders who need no introduction since their knowledge and skills are world class.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress will be a mixed event!
18-19 November | Virtual 9 am- 6 pm
21 November | APERITIF TIME, NH Milano Congress Centre 6 pm – 9 pm
22 November | Face to face, NH Milano Congress Center 9.30 am – 5 pm
APERITIF TIME – November 21 from 6 to 9 pm – NH Milano Congress
Reserve your place to meet and network with your colleagues and experts!
This year the congress will include:
– 25 Topics
– 11 virtual & face to face parallel sessions
– 25 interactives round tables
– 2 face to face workshops
– 2 LECTIO Magistralis
Perchè partecipare?
- Learn about the latest PV trends and updates
- Share experiences and solutions at A leading european event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
TOPICS 2024 IN PROGRESS
THEMATIC SESSIONS
18/11 – Virtual
– BIOLOGICAL BASIS OF ADVERSE REACTIONS WITH FOCUS ON SCARS
– IMMUNOLOGICAL ADVERSE REACTIONS
– SIGNAL DETECTION
– RISK MANAGEMENT
– COMMUNICATING SAFETY INFORMATION IN THE DIGITAL ERA
19/11 – Virtual
– AUTHORITIES’ ASSESSMENT OF PV INFORMATION
– REAL WORD DATA & REAL WORD EVIDENCE
– MANUFACTURING & PV INTERFACES
– DRUG SAFETY IN MARKETING AUTHORIZATION APPLICATIONS
– EVOLVING LANDSCAPE OF ELECTRONIC SAFETY DATA IN PV
– NON-EU PV REQUIREMENTS
22/11 – Milan
– EVOLVING PHARMACOVIGILANCE STRATEGIES
– MAIN GLOBAL AND LOCAL PV UPDATES
– PRACTICAL EXPERIENCE OF APPLYING ARTIFICIAL INTELLIGENCE IN PV
– AUDIT &INSPECTIONS
and more parallel sessions coming …
27 November 2023 - VIRTUAL / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Gian Nicola Castiglione, Director Global Pharmacovigilance, EU QPPV | Chiesi
Thierry Hamard, Pharmacovigilance & Regulatory Intelligence | Safety Observer
Marcela Fialova, COO and Co-founder | iVigee
Ilaria Grisoni, Executive Director, Head of EU/International PV & Global Risk Management and EEA QPPV | Jazz Pharmaceuticals
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Klaudija Marijanovic Barac, Sr. Director, EU&UK QPPV deputy, Head Periodic Reports & Risk Management Unit at TEVA
Qun-Ying Yue, Associate Professor, Senior Pharmacovigilance Expert | Uppsala Monitoring Centre
Zeljana Margan Koletic, Senior Manager, Risk Management Plans (RMP) Team Leader | Teva
Annette Rudolph, Pharmacovigilance scientist | Uppsala Monitoring Centre
Michael Von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars | Biogen International
Thomas Debray, Founder, Smart Data Analysis and Statistics B.V.
Susana Perez-Gutthann, Vice President, Global Head Epidemiology | RTI International
Gianluca Trifirò, Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Jan Petracek, CEO | iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Kendal Harrison, Head of Vigilance Development MHRA
Maria Beatrice Panico, Principal consultant at Scendea
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Ivona Bahnik Bisevac, Director Benefit-Risk Management | PrimeVigilance
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Slot reserved for the sponsor
Maddalena Lino, Safety risk Lead Director Pfizer
Nicholas Moore, Emeritus professor of clinical pharmacology | University of Bordeaux
28 November 2023 - VIRTUAL / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Margherita D’Antuono, EU-UK QPPV | Piramal Critical Care
Fazil Afzal, Senior Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Eriko Ogura, Global Head of Drug Safety | Shionogi & Co.,Ltd.
Niteeka Maroo, Head Pharmacovigilance | Piramal Group-India
Hervé Le Louët, Head of PV policy intelligence strategy | Takeda, CIOMS President
Frederic Bouder, Professor in Risk Management, University of Stavanger, Norway
Anita Blackburn, Global Labeling Lead | Labcorp
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Nuccia Oneto, Patient Oriented Programmes Governance Lead | Novartis Italy
Chairperson PEC
Calin Lungu, DDCS S.A., CEO
Mattia Calissano, Head of Pharmacovigilance | Orchard Therapeutics
Jan Petracek, CEO | iVigee
Larissa Mege, Global Safety Officer, Sanofi Rare Diseases, Specialty Care Business Unit
Anne De Groot, CEO/CSO and Director | EpiVax
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Sara Lazzarin, Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Vojtech Kvita, CVO, Co-Founder | NextPV Services
Glyn Belcher, CEO of PV Consultancy Ltd
Amalia Alexe, Policy & Liaison Lead, QPPV PRRC Office | Novartis
Jennifer Stevenson, Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation TrusT
Valentina Mancini, Senior Director Pharmacovigilance QPPV | Shionogi Europe
Romina Fernanda Heredia, PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Lana Arafat, Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Gloria Bustos, Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
1 December 2023 - FACE-TO-FACE IN MILAN / Agenda 2024 in progress
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Lembit Rago, Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Eriko Ogura, Global Head of Drug Safety- Shionogy
Ayman Ayoub, VP Business Unit Area Head Safety Surveillance & Risk Management | Pfizer
Andrew Bate, VP Safety Innovation & Analytics | GSK
Sophia Trantza, Senior pharmacovigilance expert
Anna Ruth van Troostenburg De Bruyn, Senior VP Pharmacovigilance & Epidemiology | Gilead Sciences
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Maria Beatrice Panico, Principal consultant at Scendea
Anne Ruth van Troostenburg De Bruyn, EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Elena Prokofjeva, Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Monica Da Luz Carvalho Soares, Health Regulatory Expert, Pharmacovigilance Adviser|Brazilian Health Surveillance Agency (Anvisa)
Calin Lungu, DDCS S.A., CEO
AIFA representative (invited)
PV inspector | FAGG -AFMPS (tbc)
Tea Babić, Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Hrvoje Maček, VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Laura Boga, Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Lucia Biagiotti, EU & UK QPPV, Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Andrea Pieri, Business Development Director | Pharma D&S
Scientific board 2024
Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK
Glyn Belcher
CEO | PV Consultancy Ltd
Mattia Calissano
Head of Pharmacovigilance | Orchard Therapeutics
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Past Head of Global Pharmacovigilance and EU-UK QPPV at Chiesi Farmaceutici S.p.A.
Mircea Ciuca
MD, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Calin Lungu
DDCS S.A., CEO
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV, Shionogi Europe
Jan Petracek
CEO, iVigee, Director, Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech, Chairperson for EUPV Congress
Speakers 2024 - In Progress...
Mayssa AbouGhannam
Country Safety Team Lead, Saudi Arabia, Gulf, Pakistan, Afghanistan | Johnson & Johnson
Fazil Afzal
Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Klaudija Marijanovic Barac
Sr. Director, EU&UK QPPV deputy, Head Periodic Reports and Risk Management Centre | TEVA
Andrew Bate
VP Safety Innovation & Analytics | GSK
Glyn Belcher
CEO | PV Consultancy Ltd
John -Joseph Borg
Director Post-Licensing | Malta Medicines Authority
Margherita D'Antuono
EU-UK QPPV| Piramal Critical Care
Anne De Groot
CEO/CSO and Director | Epivax
Roxana Dondera
Head of Pharmacovigilance and Risk Management Unit | National Agency for Medicine and Medical Devices of Romania
Iva Galic
Pharmacovigilance Inspector Expert | HALMED
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Terenzio Ignoni
SVP Quality and CMC | Gain Therapeutics
Vibha Jawa
Executive director | Bristol Myers Squibb
Calin Lungu
DDCS S.A., CEO
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Zeljana Margan Koletic
Senior Manager, Risk Management Plans (RMP) Team Leader | Teva
Robert Massouh
Head of (PV) Risk Management and Benefit Risk Evaluation | Gsk
Nicholas Moore
Emeritus Professor, specialist in Cardiology and Pharmacology | University of Bordeaux
Iva Novak
Head of European Pharmacovigilance and EU QPPV | Teva
Maria Beatrice Panico
Principal Consultant | Scendea
Georgios Papazisis
Professor of Clinical Pharmacology; Medical Director, Clinical Research Unit | School of Medicine, Aristotle University of Thessaloniki
Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Amy Rosemberg
Senior Director and Consultant, Immunology | EpiVax, Inc
Geeta Shanbhag
VP Pharmacovigilance and Medico- Regulatory Affairs | Ipca Laboratories Ltd
Sofia Trantza
Senior Pharmacovigilance Expert , PRAC member Greece
Chia Yu Chu
Prof. Department of Dermatology | National Taiwan University
Sponsors & Media Partners EUPV2023 - SPONSORS 2024 IN PROGRESS
Diventa sponsor
The European Pharmacovigilance Congress provides an excellent opportunity to get in touch with PV professionals and decision makers through a powerful virtual exhibition area. To sponsor the event, contact us.
Sede del congresso
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on November 22! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
Iscriviti alla conferenza
Face to Face (22/11/24) |
400€ |
Virtual (18-19/11/24) |
600€ |
Virtual + Face to Face (18-19/11/24 e 22/11/24) |
750€ |
* Ospedali, università e liberi professionisti ottengono uno sconto del 40% da applicare ai prezzi pubblicati (gli sconti non sono cumulabili).